Last reviewed · How we verify
NCT07207512: EFT-PGD
Emotion-Focused Therapy in the Treatment of Prolonged Grief Disorder
NA trial testing Emotion-Focused Therapy for Grief in Prolonged Grief Disorder (PGD) in 128 participants. Not yet recruiting.
1 September 2026
Quick facts
| Lead sponsor | Universidad Pontificia Comillas |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 128 |
| Start date | 1 September 2026 |
| Primary completion | 1 September 2026 |
| Estimated completion | 1 December 2027 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Emotion-Focused Therapy for Grief
- Self-help intervention based on EFT
Conditions studied
- Prolonged Grief Disorder (PGD) — all drugs for Prolonged Grief Disorder (PGD) →
Sponsor
Universidad Pontificia Comillas
Who can join
18 and older, any sex, with Prolonged Grief Disorder (PGD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if Emotion-Focused Therapy (EFT) works to reduce symptoms of Prolonged Grief Disorder (PGD) in adults. PGD happens when the pain of losing a loved one lasts a long time and causes serious problems in daily life. * The main questions this study aims to answer are: 1. Does EFT lower grief symptoms in adults with PGD? 2. Does EFT also help with related problems, such as anxiety, depression, trauma, and overall distress? * Who can take part: Adults (18 years or older) who lost a loved one at least 6 months ago and meet the criteria for PGD. \- What will happen in the study: Participants will be randomly assigned to one of two groups: 1. EFT group: 8 to 10 weekly, face-to-face therapy sessions with a trained therapist. 2. Self-help group: 10 weekly self-help exercises based on EFT, completed on their own. * All participants will complete questionnaires on grief, mood, and well-being before starting, during the study, at the end of treatment (12 weeks), and again at 5 months and 12 months after starting. * In the EFT group, the therapeutic relationship will also be measured during sessions 3 and 8. * Why this study is important: Most current treatments for grief are based on cognitive-behavioral therapy, but not everyone benefits from them. EFT is a promising therapy that focuses on emotions and has shown positive results for other mental health problems. This trial will test if EFT can be an effective treatment for people struggling with prolonged grief.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07207512
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prolonged Grief Disorder (PGD)
Currently open trials in the same condition.
- NCT06932120 — Technology-supported Interventions for Prolonged Grief Disorder (PGD) · NA · recruiting
Other Universidad Pontificia Comillas trials
Trials by the same sponsor.
- NCT07520864 — Effects of Caffeine on Elite Weightlifting Performance · NA · completed
- NCT07497035 — Equine Therapy Programme on Stress, Autonomy and Balance in School-age Children With Intellectual Disabilities · NA · active not recruiting
- NCT06727487 — OvS Breast: Ovarian Suppression in Breast Cancer Interventions · NA · recruiting
- NCT07129863 — Caffeine Mouth Rinsing at Different Doses in Female Team-Sport Athletes: A Randomized, Double-Blind, Placebo-Controlled · NA · completed
- NCT06606158 — Rehabilitation in Total Hip Arthroplasty Through a Mobile Application · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07207512 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Pontificia Comillas
- Last refreshed: 4 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07207512.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing